511509 VIVOBIOT

Vivo Bio Tech Share Price

 

 

Start SIP in VIVOBIOT

Start SIP

Performance

  • Low
  • ₹28
  • High
  • ₹29
  • 52 Week Low
  • ₹25
  • 52 Week High
  • ₹45
  • Open Price₹28
  • Previous Close₹29
  • Volume17,610
  • 50 DMA₹29.94
  • 100 DMA₹31.62
  • 200 DMA₹33.78

Investment Returns

  • Over 1 Month -5.89%
  • Over 3 Month -10.63%
  • Over 6 Month -18.68%
  • Over 1 Year -34.53%

Smart Investing Starts Here Start SIP with Vivo Bio Tech for Steady Growth!

Invest Now

Vivo Bio Tech Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 11.5
  • PEG Ratio
  • -0.3
  • Market Cap Cr
  • 47
  • P/B Ratio
  • 0.5
  • Average True Range
  • 1.83
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.6
  • RSI
  • 48.47
  • MFI
  • 41.96

Vivo Bio Tech Financials

Vivo Bio Tech Technicals

EMA & SMA

Current Price
₹29.25
+ 0.25 (0.86%)
pointer
  • Bearish Moving Average 8
  • Bullish Moving Average 8
  • 20 Day
  • ₹28.86
  • 50 Day
  • ₹29.94
  • 100 Day
  • ₹31.62
  • 200 Day
  • ₹33.78

Resistance and Support

28.81 Pivot Speed
  • R3 30.38
  • R2 29.83
  • R1 29.36
  • S1 28.34
  • S2 27.79
  • S3 27.32

Vivo Bio Tech Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-02-13 Quarterly Results
2025-11-14 Quarterly Results
2025-08-12 Quarterly Results
2025-05-19 Audited Results
2025-01-09 Quarterly Results

Vivo Bio Tech F&O

Vivo Bio Tech Shareholding Pattern

35.16%
32.7%
32.14%

Vivo Bio Tech FAQs

Vivo Bio Tech share price is ₹29 As on 12 February, 2026 | 01:30

The Market Cap of Vivo Bio Tech is ₹47.2 Cr As on 12 February, 2026 | 01:30

The P/E ratio of Vivo Bio Tech is 11.5 As on 12 February, 2026 | 01:30

The PB ratio of Vivo Bio Tech is 0.5 As on 12 February, 2026 | 01:30

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23